How AI Innovations at GCCs Solidifying India's Position in Global Life Sciences Industry

India's life sciences sector is undergoing a major transformation, led by the expansion of Global Capability Centres GCCs). These centres, which serve as strategic hubs for multinational companies in pharmaceuticals, biotechnology, and healthcare, are strengthening India's role in the global life sciences landscape. Currently, there are over 95 life sciences GCCs in India, employing approximately 280,000 professionals. By 2030, this number is projected to reach 160 GCCs and around 420,000 employees. Advancements in artificial intelligence AI) are central to this transformation, driving innovation across drug discovery and clinical research. India's life sciences GCCs have evolved from operational support centres to world-class R&D engines, leveraging India’s robust talent pool, advanced technology adoption, and cost advantages. These GCCs are driving the future of Al-powered drug discovery and clinical research. Let’s explore further.

- 

The Indian government has launched several initiatives to support the expansion of GCCs in the life sciences sector. Programmes like the "Make in India" initiative encourage foreign investment in pharmaceutical manufacturing and R&D. The National Health Policy aims to boost healthcare solutions, with a focus on local innovation, driving life sciences companies to establish R&Dfocused GCCs. In AI, the $1.25 billion IndiaAI Mission strengthens the country’s AI ecosystem, helping GCCs adopt AI for faster drug development and efficient clinical trials. The Ayushman Bharat Digital Mission connects 500 million people to digital healthcare services, enhancing India’s healthcare system. Additionally, Special Economic Zones (SEZs) and Biotechnology Parks provide critical infrastructure and tax incentives, facilitating the growth of life sciences GCCs aligning with India’s broader vision to lead in pharmaceutical R&D innovation.

State-Level Leadership: Karnataka and Telangana

Among Indian states, Karnataka and Telangana stand out as key locations for the development of life sciences GCCs. Both states have created strong ecosystems that attract global investment and skilled professionals, enhancing the growth of the sector.